Polymeric Micelle Nanoparticles for Targeted Cargo Packaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer vaccines face challenges with weak immunogenicity, low specificity, and off-target effects, and have limited ability to control anti-tumor immune responses effectively, while exosomes for therapeutic delivery suffer from low secretion and limited packaging capacity.
Innovation Solution
Development of polymeric micelle nanoparticles that form extracellular vesicles with a cargo molecule of choice by using amphiphilic block copolymers with reversible linkages, allowing for site-specific packaging and targeted delivery through targeting molecules.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If exosomes are used for therapeutic delivery, then they can serve similar biological functions to parent cells, but low secretion and limited packaging capacity remain significant obstacles
Solution Approach 1:
The patent embeds polymeric micelles containing cargo molecules inside exosomes, creating a nested structure where the micelle (outer container) holds the therapeutic cargo and the exosome (inner container) provides biological functionality. This nested architecture significantly increases the packaging capacity of exosomes while maintaining their natural secretion mechanisms.
Solution Approach 2:
The invention divides the therapeutic delivery system into separate functional components: polymeric micelles for cargo loading and targeting, and exosomes for biological activity and secretion. This segmentation allows independent optimization of packaging capacity (via micelle design) and secretion efficiency (via exosome properties).
2Reliability
If traditional cancer vaccines are used, then they can modulate immune responses, but they suffer from weak immunogenicity, low specificity, and off-target effects
Solution Approach 1:
The patent incorporates targeting ligands on the polymeric micelle surface that specifically recognize and bind to receptors on tumor cells or antigen-presenting cells. This local targeting capability ensures that the therapeutic cargo is delivered precisely to the intended cells, enhancing specificity while minimizing off-target effects.
Solution Approach 2:
The polymeric micelle acts as an intermediary carrier that bridges the gap between the therapeutic cargo and the target cells. It provides controlled release of cargo molecules at the target site and facilitates efficient uptake by target cells through receptor-mediated endocytosis, thereby improving reliability and reducing harmful off-target effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the loading and delivery of therapeutic molecules into extracellular vesicles, improving their immunogenicity and specificity, and enabling precise control of anti-tumor immune responses with minimal off-target effects.
Implementation Method 1
a first amphiphilic block copolymer having at least one reversible linkage to at least one cargo molecule
Implementation Method 2
polymeric micelle nanoparticles comprising a first amphiphilic block copolymer... and a second amphiphilic block copolymer
Implementation Method 3
a second amphiphilic block copolymer covalently linked to a targeting molecule
Data Source
AI summary
Described are polymeric micelle nanoparticles and their use in producing extracellular vesicles containing a cargo molecule. The cargo-loaded extracellular vesicles can be used as therapeutic delivery vectors.